Cabot Creamery takes its show on the road
CAPITAL REGION, N.Y. Cabot Creamery has begun a nationwide road tour promoting the benefits of calcium in fighting childhood obesity and osteoporosis. The tour has hit the New York Capital District and is set to stop at more than 12 Price Chopper Supermarkets in the area.
Cabot’s road crew will be handing out coupons, prizes and recipes, as well as samples of Cabot’s classic cheeses, including new mega-3 cheddar.
Cabot spokesman Mark Hackett told the media: “One thing Cabot is famous for is its cheddar cheese, and cheddar cheese is lactose free. So a lot people who are avoiding dairy still need their source of calcium and the best source of calcium is naturally through cheese, yogurt, or milk.”
The Cabot Road Show will be visiting cities nationwide to promote its message of healthy weight loss.
American Licorice Company banks on capital investments to carry it through tough times
UNION CITY, Calif. American Licorice Company is counting on its “rainy day” savings funds to carry it through economic hard times, The San Francisco Chronicle this week reported.
The maker of well-beloved licorice treat Red Vines has said that it hopes that the $10 million in capital investments the company has banked in good years will be enough to carry it through the current cash-poor economy.
“We won’t call it recession-proof, but licorice has always held its own. It’s kind of a comfort food,” American Licorice plant manager John Nelson told the Chronicle. Still, touch times lay ahead for many independent companies. “Lines of credit are being frozen or reduced. … Or if they are new requests, may not be approved.”
To help buoy the effects of marketplace money drain, Nelson told the media, American Licorice Company is constantly seeking ways to improve productivity and efficiency. The company will also continue investing, he said, in order to keep its profit dollars flowing.
FDA selects contractors to lead IT, data systems management
WASHINGTON The Food and Drug Administration announced Tuesday that it had selected 10 contractors to receive a total of up to $2.5 billion for information technology and data center management services over the next 10 years.
The agency said the contract was a cornerstone of its Information Technology for the 21st Century bioinformatics initiative, a modernization program that includes data management, data warehousing, IT infrastructure and IT security.
“This contract sets the stage for the FDA to have IT to acquire, analyze and act on data critical for import protection, food protection and medical product safety plans,” commissioner of food and drugs Dr. Andrew von Eschenbach said. “We are creating a high-tech, efficient data-management system designed to meet the needs of those who must accomplish our mission‹protecting and promoting the health of the American public.”
Contracts worth at least $25,000 each went to Buccaneer, Computer Sciences Corporation, Dynanet, Electronic Data Systems, General Dynamics, Human Touch, IDL-Pragmatics, Interactive Technology Solutions, Telesis and Unisys.
Three companies have received task orders to design and migrate systems applications to new data centers, which the FDA said would be the cornerstone of its IT infrastructure and bioinformatics modernization for the next 10 years. IT Solutions received $3 million to design, implement and migrate existing FDA applications to the newly configured White Oak Data Center to support test and development applications; Buccaneer received $3 million to operate and maintain the data center; EDS received $12 million to design, implement and migrate applications to a “contractor owned, contractor operated” hosted data center for FDA production operations.